These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12035642)

  • 41. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Asthma control.
    van Schayck CP; van Herwaarden CL; van Weel C
    Lancet; 1994 Jul; 344(8916):194. PubMed ID: 7912787
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical Progress Note: Care of Children Hospitalized for Acute Asthma Exacerbation.
    Andrews AL; Williams DC; Hogan AH
    J Hosp Med; 2020 Jul; 15(7):416-418. PubMed ID: 32118556
    [No Abstract]   [Full Text] [Related]  

  • 44. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma.
    Skoner DP; Greos LS; Kim KT; Roach JM; Parsey M; Baumgartner RA
    Pediatr Pulmonol; 2005 Dec; 40(6):477-86. PubMed ID: 16193496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
    Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF
    Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salmeterol and paroxetine: more evidence for paradoxical medicine.
    Yun AJ; Lee PY; Doux JD
    Med Hypotheses; 2006; 66(5):1037-8. PubMed ID: 16364562
    [No Abstract]   [Full Text] [Related]  

  • 48. A young girl with apparent treatment-resistant asthma treated at Bambino Gesù children's hospital.
    Petreschi F; Ullmann N; Bottero S; Tomà P; Inserra A; Francalanci P; Zicari AM; Cutrera R
    Thorax; 2014 Apr; 69(4):396-8. PubMed ID: 24368714
    [No Abstract]   [Full Text] [Related]  

  • 49. What constitutes a "clinically significant" bronchodilator response in children?
    Guezguez F; Ben Saad H
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32381631
    [No Abstract]   [Full Text] [Related]  

  • 50. Asthma, bronchodilator drugs and education.
    Seale JP
    Med J Aust; 1984 Aug; 141(3):170-1. PubMed ID: 6749033
    [No Abstract]   [Full Text] [Related]  

  • 51. Bronchodilator Responsiveness: An Underappreciated Biomarker for Asthma Exacerbations.
    Busse WW; Panettieri RA; Corren J
    J Allergy Clin Immunol Pract; 2022 Jan; 10(1):229-230. PubMed ID: 35000733
    [No Abstract]   [Full Text] [Related]  

  • 52. Placebo and other interventions in asthma.
    Straumann A; Safroneeva E; Schoepfer AM
    N Engl J Med; 2011 Oct; 365(15):1446-7; author reply 1447-8. PubMed ID: 21995396
    [No Abstract]   [Full Text] [Related]  

  • 53. CAN BURST VENTOLIN THERAPY BE SAFELY GIVEN AT HOME TO REDUCE EMERGENCY AND HOSPITAL PRESENTATIONS WITH ASTHMA IN CHILDREN?
    Chen KYH; Lawrence J; Berry A; Hiscock H; Robertson C
    J Paediatr Child Health; 2020 Oct; 56(10):1657-1658. PubMed ID: 33099820
    [No Abstract]   [Full Text] [Related]  

  • 54. Salbutamol enantiomers: early clinical evidence in humans.
    Ind PW
    Thorax; 1997 Oct; 52(10):839-40. PubMed ID: 9404366
    [No Abstract]   [Full Text] [Related]  

  • 55. Bronchodilator Responsiveness Does Not Help Determine Anti-IL-5 Targeted Biologic Success in Patients With Severe Asthma.
    Zhao W; Hogan MB
    J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3184-3185. PubMed ID: 36496212
    [No Abstract]   [Full Text] [Related]  

  • 56. [Salbutamol as an indicator of poor asthma control].
    Vega-Briceño L
    Andes Pediatr; 2021 Oct; 92(5):809-811. PubMed ID: 35319594
    [No Abstract]   [Full Text] [Related]  

  • 57. Placebo and other interventions in asthma.
    Rolla G; Bucca C
    N Engl J Med; 2011 Oct; 365(15):1446; author reply 1447. PubMed ID: 21995394
    [No Abstract]   [Full Text] [Related]  

  • 58. Placebo and other interventions in asthma.
    Bibalo C; Panontin E; Longo G
    N Engl J Med; 2011 Oct; 365(15):1446; author reply 1447. PubMed ID: 21995395
    [No Abstract]   [Full Text] [Related]  

  • 59. The Weekday Wheezer.
    Fischer J; Ohmer M; Petersen M
    Clin Pediatr (Phila); 2017 Aug; 56(9):879-881. PubMed ID: 28633529
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug therapy X-asthma.
    Johnson RL
    Northwest Med; 1971 Feb; 70(2):87-91. PubMed ID: 5541619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.